Purchase Order 80NSSC24PB311
Award Date 8/7/24
Potential Completion Date 2/6/25
Potential Value $156K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Farmington, CT 06032, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
500
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
STTR Phase I
Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price contract awarded by the National Aeronautics and Space Administration (NASA) Shared Services Center, a civilian federal agency, to Encapsulate Inc., a self-certified small disadvantaged business. The contract, valued at $2,748,020.00, is for Encapsulate Inc.'s FY25 SBIR (Small Business Innovation Research) Phase III project titled "NVASIVE: Unraveling the Enigma of Metastasis." This contract supports the company's ongoing research and development efforts in...
- The U.S. National Aeronautics and Space Administration (NASA) Johnson Space Center awarded a $1,955,755.46 cooperative agreement to Nuvue Therapeutics Inc., a small disadvantaged business, to conduct research on microencapsulation for the development of Food and Drug Administration (FDA) packages for premarket notification (510(k) approval) of tissue imaging markers and to initiate pre-clinical trials for the encapsulation of chemotherapeutic agents. The contract has no set-aside designation and...
- This is a $1,484,350.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Shuttle Pharmaceuticals, Inc., a small business Subchapter S Corporation. The contract is for cell-based models for prostate cancer health disparity research as part of the Cancer Moonshot program (Phase II). The contract has a total small business set aside designation and an ultimate completion date of November 16, 2021. This award builds upon a previous contract with...
- This is a Small Business Innovation Research (SBIR) Concept Award issued by the National Cancer Institute, a civilian agency, for the development of therapeutic or preventative technologies to treat or prevent pediatric cancers and/or rare cancers. The $354,957.00 Firm Fixed Price contract was awarded to Metaclipse Therapeutics Corp, a self-certified small disadvantaged business, on September 5, 2025, with a completion date of September 4, 2026. The contract is set aside for total small business...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- <p>This is a $299,813 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hylapharm LLC, a self-certified small disadvantaged business, under the SBIR Program Phase I. The contract is for the development of "Targeted Nanoparticle Treatment for Breast Cancer Stem Cells." This contract has a Total Small Business set-aside designation. The contract has an ultimate completion date of September 17, 2016.</p>
- <p>This is a $299,356.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Entropia Biosciences Inc., a self-certified small disadvantaged business. The contract is for research and development in the biomedical field, specifically for a SBIR Program Phase I action. The contract has a set-aside designation for total small business. The award date was September 22, 2015, and the ultimate completion date is June 21, 2016.</p>
- This is a Definitive Contract awarded by the National Cancer Institute, a civilian agency within the U.S. Government, to Redwire Space Technologies, Inc., a for-profit small business corporation. The contract, valued at $199,992.00, is for a Firm Fixed Price with a period of performance from September 30, 2010 to September 29, 2011. The contract has a "Total Small Business" set-aside designation. The contract appears to be focused on research and technology development in support of...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- <p>This SBIR Phase I contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Transgenex Nanobiotech Inc., a minority-owned small business, for the development of a "fibrous scaffold-induced spheroids mimicking TME" solution. The contract, valued at $299,992.00, is a definitive, firm fixed-price contract with a completion date of July 21, 2014. The contract was set aside for the participation of small businesses.</p>